INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 296 filers reported holding HAEMONETICS CORP in Q2 2023. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.

Quarter-by-quarter ownership
INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2023$806
+89.2%
9
+80.0%
0.00%
Q2 2023$426
+2.9%
50.0%0.00%
Q1 2023$414
-79.3%
5
-77.3%
0.00%
Q1 2020$2,000
-33.3%
220.0%0.00%
-100.0%
Q4 2019$3,0000.0%220.0%0.00%0.0%
Q3 2019$3,000
+50.0%
22
+29.4%
0.00%
Q2 2019$2,000
+100.0%
170.0%0.00%
Q1 2019$1,000
-50.0%
170.0%0.00%
Q4 2018$2,000170.00%
Other shareholders
HAEMONETICS CORP shareholders Q2 2023
NameSharesValueWeighting ↓
LGT CAPITAL PARTNERS LTD. 1,216,059$64,500,0001.72%
HEARTLAND ADVISORS INC 406,192$21,544,0001.26%
KINGDON CAPITAL MANAGEMENT, L.L.C. 200,000$10,608,0001.22%
Aurora Investment Counsel 32,149$1,705,0001.01%
Endurant Capital Management LP 73,914$3,920,0000.95%
KINGDON CAPITAL MANAGEMENT, L.L.C. 135,000$7,160,0000.82%
ARMISTICE CAPITAL, LLC 872,000$46,251,0000.76%
Summit Creek Advisors LLC 131,357$6,967,0000.70%
Dean Capital Management 15,309$812,0000.70%
Keene & Associates, Inc. 11,720$622,0000.54%
View complete list of HAEMONETICS CORP shareholders